Daniel A. Bulzico

Rio De Janeiro, RJ 20230130, Brazil

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications

Multiple endocrine neoplasia type 2: From molecular genetics to precision therapy.

Multiple endocrine neoplasia type 2: From molecular genetics to precision therapy.

Journal: Best practice & research. Clinical endocrinology & metabolism
Published: June 15, 2026

GHRH and insulin hypersecretion from a pancreatic neuroendocrine tumor in multiple endocrine neoplasia type 1.

GHRH and insulin hypersecretion from a pancreatic neuroendocrine tumor in multiple endocrine neoplasia type 1.

Journal: JCEM case reports
Published: October 06, 2025

Real-world Data on Intermediate-risk Differentiated Thyroid Cancer Biochemical Response to 3700 or 5550 MBq of [131I]Sodium Iodide.

Real-world Data on Intermediate-risk Differentiated Thyroid Cancer Biochemical Response to 3700 or 5550 MBq of [131I]Sodium Iodide.

Journal: Current radiopharmaceuticals
Published: November 27, 2024

Is peptide receptor radionuclide therapy still a promising option for medullary thyroid carcinoma?

Is peptide receptor radionuclide therapy still a promising option for medullary thyroid carcinoma?

Journal: Endocrine
Published: October 05, 2024

Gastric neuroendocrine neoplasms: analysis of a cohort of patients followed at the Brazilian National Cancer Institute.

Gastric neuroendocrine neoplasms: analysis of a cohort of patients followed at the Brazilian National Cancer Institute.

Journal: Endocrine oncology (Bristol, England)
Published: October 02, 2024

Perspective review: lessons from successful clinical trials and real-world studies of systemic therapy for metastatic pheochromocytomas and paragangliomas.

Perspective review: lessons from successful clinical trials and real-world studies of systemic therapy for metastatic pheochromocytomas and paragangliomas.

Journal: Therapeutic advances in medical oncology
Published: September 04, 2024

Improvement of Laboratory Hepatic Parameters After Treatment With 177 Lu-DOTATATE : Cohort in an Oncology Reference Center.

Improvement of Laboratory Hepatic Parameters After Treatment With 177 Lu-DOTATATE : Cohort in an Oncology Reference Center.

Journal: Clinical nuclear medicine
Published: August 01, 2024

Epidemiological profile of neuroendocrine tumors in adults in Brazil.

Epidemiological profile of neuroendocrine tumors in adults in Brazil.

Journal: Archives of endocrinology and metabolism
Published: May 06, 2024

Radioiodine treatment in female survivors of pediatric differentiated thyroid carcinoma does not affect future pregnancy rates.

Radioiodine treatment in female survivors of pediatric differentiated thyroid carcinoma does not affect future pregnancy rates.

Journal: Archives of endocrinology and metabolism
Published: January 26, 2024

External beam radiation therapy for recurrent or residual thyroid cancer: What is the best treatment time and the best candidate for long-term local disease control?

External beam radiation therapy for recurrent or residual thyroid cancer: What is the best treatment time and the best candidate for long-term local disease control?

Journal: Head & neck
Published: December 30, 2023

Serum anti-Müllerian hormone is lower in patients with multiple radioiodine dose for treatment of pediatric thyroid cancer.

Serum anti-Müllerian hormone is lower in patients with multiple radioiodine dose for treatment of pediatric thyroid cancer.

Journal: European thyroid journal
Published: December 04, 2023

Stimulated thyroglobulin and diagnostic 131-iodine whole-body scan as a predictor of distant metastasis and association with response to treatment in pediatric thyroid cancer patients.

Stimulated thyroglobulin and diagnostic 131-iodine whole-body scan as a predictor of distant metastasis and association with response to treatment in pediatric thyroid cancer patients.

Journal: Endocrine
Published: October 11, 2023
Showing 1-12 of 43

Last Updated: 09/26/2026